Q1 2025 Holdings
Filed 2025-05-13 | 13 holdings | $288.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BridgeBio Pharma Inc. (Bbio)(BBIO) | COM | 10806X102 | $209.8M | 6,068,125 | 72.7% |
| Verona Pharma plc (Vrna)(VRNA) | SPONSORED ADS | 925050106 | $39.1M | 615,352 | 13.5% |
| Syndax Pharmaceuticals, Inc. (Sndx)(SNDX) | COM | 87164F105 | $12.6M | 1,025,000 | 4.4% |
| Bicara Therapeutics Inc. (Bcax)(BCAX) | COM | 055477103 | $7.4M | 568,919 | 2.6% |
| Monte Rosa Therapeutics Inc (Glue)(GLUE) | COM | 61225M102 | $6.8M | 1,472,331 | 2.4% |
| Nuvation Bio Inc. (Nuvb)(NUVB) | COM CL A | 67080N101 | $4.5M | 2,541,009 | 1.6% |
| Compass Pathways Plc (Cmps)(CMPS) | SPONSORED ADS | 20451W101 | $3.4M | 1,198,418 | 1.2% |
| Biomea Fusion Inc (Bmea)(BMEA) | COM | 09077A106 | $1.7M | 798,757 | 0.6% |
| CalciMedica, Inc. (Calc)(CALC) | COM NEW | 38942Q202 | $995.3K | 521,114 | 0.3% |
| Elevation Oncology Inc (Elev) | COM | 28623U101 | $734.5K | 2,834,910 | 0.3% |
| Aclaris Therapeutics Inc (Acrs)(ACRS) | COM | 00461U105 | $664.7K | 434,455 | 0.2% |
| Marker Therapeutics, Inc. (Mrkr)(MRKR) | COM NEW | 57055L206 | $400.2K | 325,370 | 0.1% |
| OnKure Therapeutics, Inc. (Okur)(OKUR) | COM CL A | 68277Q105 | $381.0K | 88,607 | 0.1% |